| Translated title of the contribution | Neoadjuvant therapy schemes combined with adjuvant therapy in muscle-invasive bladder cancer before and after radical cystectomy, respectively: A randomized, open, multicenter, global phase III trial to determine the efficacy and safety of durvalumab in combination with gemcitabine+cisplatin (G+C) for the neoadjuvant treatment, followed by durvalumab only for the adjuvant treatment in patients with muscle-invasive bladder cancer (NIAGARA) - AB 74/20 of the AUO |
|---|---|
| Original language | German |
| Pages (from-to) | 220-221 |
| Number of pages | 2 |
| Journal | Aktuelle Urologie |
| Volume | 52 |
| Issue number | 3 |
| DOIs |
|
| State | Published - 21 May 2021 |
| Externally published | Yes |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver